The Enterprise Value as of November 2024 (TTM) for argenx SE (ARGX) is 35.17B

According to argenx SE’s latest financial reports and current stock price. The company's current Enterprise Value is 35.17B. This represents a change of 98.04% compared to the average of 17.76B of the last 4 quarters.

argenx SE (ARGX) Historical Enterprise Value (quarterly & annually)

How has ARGX Enterprise Value performed in the past?

The mean historical Enterprise Value of argenx SE over the last ten years is 7.55B. The current 35.17B Enterprise Value has changed 46.51% with respect to the historical average. Over the past ten years (40 quarters), ARGX's Enterprise Value was at its highest in in the September 2023 quarter at 30.47B. The Enterprise Value was at its lowest in in the June 2020 quarter at -1343438115.00.

argenx SE (ARGX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of argenx SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

argenx SE (ARGX) Average Enterprise Value

How has ARGX Enterprise Value performed in the past?

The current Enterprise Value of argenx SE (ARGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

argenx SE (ARGX) Enterprise Value vs. Peers

How is ARGX’s Enterprise Value compared to its peers?

argenx SE’s Enterprise Value is greater than IVERIC bio, Inc. (5.13B), greater than Blueprint Medicines Corporation (6.36B), greater than Amylyx Pharmaceuticals, Inc. (291.98M), greater than Karuna Therapeutics, Inc. (12.43B), greater than Day One Biopharmaceuticals, Inc. (963.46M), greater than Mirati Therapeutics, Inc. (3.91B), greater than Terns Pharmaceuticals, Inc. (222.97M), greater than Apellis Pharmaceuticals, Inc. (3.90B), greater than Legend Biotech Corporation (7.40B), greater than Zai Lab Limited (2.48B), less than Seagen Inc. (42.84B), greater than Alnylam Pharmaceuticals, Inc. (31.79B), greater than Ascendis Pharma A/S (7.61B), greater than Vaxcyte, Inc. (10.01B), greater than Travere Therapeutics, Inc. (1.95B), greater than Akero Therapeutics, Inc. (2.00B), greater than BeiGene, Ltd. (19.75B),

Build a custom stock screener for argenx SE (ARGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like argenx SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

argenx SE (ARGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like argenx SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.